HOME >> MEDICINE >> NEWS
NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks

The National Institute of Allergy and Infectious Diseases (NIAID) today announced the clinical investigators and institutions that will lead NIAID's newly restructured HIV/AIDS clinical trials networks in the search for safe and effective treatments and prevention strategies, including HIV vaccines. NIAID, part of the National Institutes of Health (NIH), supports the world's largest portfolio of clinical HIV/AIDS research.

"The new network structure expands our clinical research capacity and strengthens our ability to take advantage of emerging scientific opportunities," says NIAID Director Anthony S. Fauci, M.D. "By creating a more integrated, collaborative and flexible structure, we will be better equipped to meet evolving global AIDS research priorities."

These leadership group awards represent the first step of the two-part restructuring process of the HIV/AIDS clinical trials networks. Awards for the Clinical Trials Units (CTUs), which will carry out the clinical research, are expected to be announced later this year.

Each leadership group will be led by a principal investigator and include a core operations group that will provide administrative and technical support; a statistical and data management center; and a network laboratory structure. The following principal investigators and institutions will lead the newly restructured HIV/AIDS networks:

  • AIDS Clinical Trials Group (ACTG)--Constance A. Benson, M.D., University of California, San Diego
  • HIV Prevention Trials Network (HPTN)--Sten Vermund, M.D., Ph.D., Vanderbilt University, Nashville
  • HIV Vaccine Trials Network (HVTN)--Lawrence Corey, M.D., The Fred Hutchinson Cancer Research Center, Seattle
  • International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)--Jay Brooks Jackson, M.D., Johns Hopkins University School of Medicine, Baltimore
  • Interna
    '"/>


Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
29-Jun-2006


Page: 1 2 3

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. NIAID awards $4 million to develop anti-radiation treatments
5. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2018)... ... November 09, 2018 , ... The event takes place on Wednesday, November 14, ... The Memory Care was recently updated because of the generous supporters of Eskaton Foundation. ... with dementia. “Dementia is a feared word in today’s society and is often misunderstood,” ...
(Date:11/9/2018)... SAN FRANCISCO (PRWEB) , ... November 09, 2018 ... ... the leader in microbial genomics, has awarded microbiome research support in study design, ... Spain led by Dr. Isabel Sospedra, PhD, to study the effects of a ...
(Date:11/9/2018)... ... 08, 2018 , ... Chapters Health System and ... LifePath Hospice ) announced today Dean H. Forman, MBA, will start officially as ... directly to President and Chief Executive Officer Andrew Molosky. In 2017, Chapters Health ...
(Date:11/8/2018)... ... November 08, 2018 , ... ... reported among different media sources could impact how they view advertising and earned ... (FMMS). Market Connections, Inc. will release results of the tenth annual study of ...
(Date:11/8/2018)... PASS, Ore. (PRWEB) , ... November 08, 2018 , ... ... in celebration of Breast Cancer Awareness Month. For each custom “Be Aware” mug sold ... , “We are so proud of the support our customers showed for these ...
Breaking Medicine News(10 mins):
(Date:11/9/2018)... ... , ... After just more than a year in business, ... – Caring Transitions of Cleveland Western Suburbs – to include the east side ... will now be doing business as Caring Transitions of Cleveland Western Suburbs and ...
(Date:11/8/2018)... ... November 08, 2018 , ... Health Velocity Capital ... affiliated funds with more than $185 million in committed capital. The fund ... helping to build innovative healthcare software and services businesses that contribute to a ...
(Date:11/8/2018)... ... November 08, 2018 , ... From November 1 to December 31, the ... to the Alamo Breast Cancer Foundation. “Cancer is a nightmare,” said Gloria Gonzales, broker ... the imagination can really capture it. When it happens to you, then you know. ...
Breaking Medicine Technology:
Cached News: